Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Population Pharmacokinetic Modeling of Glycochenodeoxycholic Acid 3‐O‐Sulfate (GCDCA‐S) as Endogenous Biomarker of OATP1B3 and OAT3 Transporters

  • Source: Ujihira, Y, Georgiev, V, Ogungbenro, K & Galetin, A 2025, 'Population Pharmacokinetic Modeling of Glycochenodeoxycholic Acid 3‐O‐Sulfate (GCDCA‐S) as Endogenous Biomarker of OATP1B3 and OAT3

Record details

×
Academic Journal

Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data

  • Source: Cleary, Y, Milani, N, Ogungbenro, K, Aarons, L, Galetin, A & Gertz, M 2025, 'Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data', The AAPS journal,

Record details

×
Academic Journal

Evaluation of Adefovir PBPK Model to Assess Biomarker‐Informed OAT1 Drug–Drug Interaction and Effect of Chronic Kidney Disease

Subjects: Organic Anion Transporters; Endogenous Biomarker; Chronic Kidney Disease

  • Source: Tan, S P F, Wu, H, Rostami‐Hodjegan, A, Scotcher, D & Galetin, A 2025, 'Evaluation of Adefovir PBPK Model to Assess Biomarker‐Informed OAT1 Drug–Drug Interaction and Effect of Chronic Kidney

Record details

×
Academic Journal

Establishing a physiologically-based pharmacokinetic framework for aldehyde oxidase and dual aldehyde oxidase-CYP substrates

  • Source: Izat, N, Bolleddula , J, Carione, P, Huertas Valentin, L, Jones, R S, Kulkarni, P, Moss, D, Peterkin, V C, Tian, D-D, Treyer, A, Venkatakrishnan, K, Zientek, M A, Barber, J, Houston, J, Galetin, A &

Record details

×
Academic Journal

Evaluating drug-drug interaction risk associated with peptide analogues using advanced in vitro systems

  • Source: Nørgaard, R A, Bhatt, D K, Järvinen, E, Stage, T B, Gabel-Jensen, C, Galetin, A & Säll, C 2024, 'Evaluating drug-drug interaction risk associated with peptide analogues using advanced in vitro

Record details

×
Academic Journal

Development of 4-Pyridoxic Acid PBPK Model to Support Biomarker- Informed Evaluation of OAT1/3 Inhibition and Effect of Chronic Kidney Disease

Subjects: Drug-drug interaction; Endogenous Biomarker; Chronic Kidney Disease

  • Source: Tan, S P F, Willemin, M, Snoeys, J, Shen, H, Rostami‐hodjegan, A, Scotcher, D & Galetin, A 2023, 'Development of 4-Pyridoxic Acid PBPK Model to Support Biomarker- Informed Evaluation of OAT1/3

Record details

×
Academic Journal

Drug-drug interaction database for safe prescribing of systemic antifungal agents

  • Source: Niazi-Ali, S, Atherton, G T, Walczak, M & Denning, D W 2021, 'Drug-drug interaction database for safe prescribing of systemic antifungal agents', Therapeutic advances in infectious disease, vol. 8,

Record details

×
Academic Journal

Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to Children:Risdiplam in Pediatric Patients With Spinal Muscular Atrophy

Subjects: Adolescent; Adult; Azo Compounds/pharmacokinetics

  • Source: Fukushima (Cleary), Y, Gertz, M, Grimsey, P, Günther, A, Heinig, K, Ogungbenro, K, Aarons, L, Galetin, A & Kletzl, H 2021, 'Model-Based Drug-Drug Interaction Extrapolation Strategy From Adults to

Record details

×
Academic Journal

Predicting human tissue exposures to xenobiotics using a bottom-up physiologically-based biokinetic model

  • Source: Tan, P F S 2021, 'Predicting human tissue exposures to xenobiotics using a bottom-up physiologically-based biokinetic model', ALTEX. https://doi.org/10.14573/altex.2007151

Record details

×
  • 1-10 of  26 results for ""DDI""